ARTICLE | Clinical News

CMV trivalent vaccine: Phase I data

May 2, 2005 7:00 AM UTC

Data from an open-label, U.S. Phase I trial in about 40 healthy adults with and without prior CMV exposure showed that both doses of the trivalent vaccine were well tolerated and induced antibody and ...